Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news

    Tag: pharma news

    You Searched For "pharma news"
    Alkem Labs Founder Samprada Singh passes away at the age of 92 years

    Alkem Labs Founder Samprada Singh passes away at the age of 92 years

    Medical Dialogues Bureau29 July 2019 9:00 AM IST
    Patna: Mumbai-based drugmaker, Alkem Laboratories Founder and Chairman Emeritus, Samprada Singh expired on Saturday at the age of 92 years after a...
    Jubilant Life Sciences net profit slips 7.68 percent to Rs 185 crore for June quarter

    Jubilant Life Sciences net profit slips 7.68 percent to Rs 185 crore for June quarter

    Farhat Nasim29 July 2019 9:00 AM IST
    "We have had a steady performance during the quarter. Pharmaceutical segment revenues have been higher by 12 per cent YoY led by growth in CMO,...
    DOP junks Geltec plea against NPPA decision on retail price of Ibuprofen Soft Gelatin Capsules

    DOP junks Geltec plea against NPPA decision on retail price of Ibuprofen Soft Gelatin Capsules

    Farhat Nasim28 July 2019 11:30 AM IST
    New Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Geltec Private Limited...
    Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

    Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

    Medical Dialogues Bureau28 July 2019 9:17 AM IST
    Sales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
    Indoco Remedies receives EIR from USFDA for sterile, solid dosages facility in Goa

    Indoco Remedies receives EIR from USFDA for sterile, solid dosages facility in Goa

    Medical Dialogues Bureau27 July 2019 9:45 AM IST
    The inspection was held from May 27-June 4, 2019 and the company received four Form 483 observations, Indoco Remedies said in a filing to BSE.NEW...
    Biocon appoints Mayank Verma as Company Secretary, Compliance Officer

    Biocon appoints Mayank Verma as Company Secretary, Compliance Officer

    Farhat Nasim27 July 2019 9:00 AM IST
    Prior to joining the Biocon Group, Mayank Verma has worked with ING Vysya Bank Limited from 2007 to 2012.New Delhi: Biotechnology major, Biocon has...
    Apixaban Patent: Natco gets HC relief for its upcoming medicine Apigat

    Apixaban Patent: Natco gets HC relief for its upcoming medicine Apigat

    Farhat Nasim26 July 2019 3:00 PM IST
    NEW DELHI: Days after ending a patent row over its cancer drug Regonat with Bayer, drugmaker, Natco Pharma is reported to have now been embroiled in a...
    Zydus Cadila launches Ramelteon tablets in US to treat insomnia

    Zydus Cadila launches Ramelteon tablets in US to treat insomnia

    Medical Dialogues Bureau25 July 2019 11:23 AM IST
    In a BSE filing, Zydus Cadila announced the "launch of Ramelteon tablets, 8 mg upon receiving the final approval from the USFDA. Ramelteon is a...
    Pfizer gets USFDA nod for biosimilar to Rituximab

    Pfizer gets USFDA nod for biosimilar to Rituximab

    Medical Dialogues Bureau25 July 2019 8:59 AM IST
    Ruxience is a mAb biosimilar to Rituxan which works by targeting a protein called CD20, which is present on the surface of B cells. Ruxience is...
    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    Medical Dialogues Bureau24 July 2019 12:16 PM IST
    NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
    Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore

    Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore

    Medical Dialogues Bureau24 July 2019 9:30 AM IST
    The firm's India business was up nine per cent year-on-year to Rs 907 crore for the quarter. The US revenues at Rs 376 crore were up by 13 per cent...
    Sanofi strikes deal for US rights to Roche Tamiflu

    Sanofi strikes deal for US rights to Roche Tamiflu

    Medical Dialogues Bureau24 July 2019 9:15 AM IST
    Under the terms of the agreement, Sanofi will be responsible for leading FDA negotiations for the OTC switch and subsequent exclusive marketing,...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok